Loading stock data…
West Pharmaceutical Services, I (WST)
$354.68+3.83 (+1.09%)
Market ClosedLast close Jun 29
West Pharmaceutical Services, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
West Pharmaceutical Services, Inc. in the Healthcare sector is trading at $354.68 with a market capitalization of $22.8B. Wall Street consensus targets $358.79 (14 analysts), implying a +1.2% move over the next 12 months. The stock is currently near its 52-week high of $355.12, remaining 29.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $844.90M↑ | $805.00M | $804.60M↑ | $766.50M↑ | $698.00M |
| Gross Profit | $296.40M↓ | $303.90M↑ | $294.30M↑ | $273.90M↑ | $231.90M |
| Operating Income | $181.10M↑ | $175.10M↑ | $174.50M↑ | $158.90M↑ | $127.60M |
| Net Income | $138.80M↑ | $132.10M↓ | $140.00M↑ | $131.80M↑ | $89.80M |
Peer Comparison
JNJUNHPFE
Fundamentals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Pro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$22.76B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
43.13
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.17
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.25%
ROE
Elite ROE. Management converts capital into profit efficiently.
18.15%
Volume
Today's trading volume
521,799
Recent News
AMN Expands Workforce Intelligence Through Brightfield Alliance
AMN Healthcare's alliance with Brightfield boosts workforce intelligence, pairing TDX with analytics to support smarter healthcare labor planning.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
1 High-Flying Stock Worth Your Attention and 2 Facing Challenges
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
MiniMed Launches Abbott's Instinct Sensors Across European Markets
MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
ECL's strong Q1 earnings, digital growth and expanding high-tech platform support long-term upside despite rising cost pressures.